Contribute Try STAT+ Today

The European Commission fined a unit of Merck KGaA $9 million for providing incorrect or misleading information during an investigation of a deal in which the drug maker spent $17 billion to acquire Sigma-Aldrich, which was a U.S. supplier of laboratory testing materials.

The EC, which is the executive arm of the European Union, had approved the deal in June 2015, but only on the condition that the companies agreed to sell certain portions of their lab chemicals business. At the time, there were concerns the merger would reduce competition, because Merck (MKKGY) and Sigma-Aldrich were the two leading suppliers of solvents and inorganics.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.